Kiniksa Pharmaceuticals International (KNSA) Amortizatization of Intangibles (2018 - 2026)

Kiniksa Pharmaceuticals International has reported Amortizatization of Intangibles for 9 years, with the latest figure at -$1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles fell 410.59% year-over-year to -$1.3 million; the trailing twelve-month figure through Mar 2026 stood at -$131000.0 (up 67.17% YoY), and the FY2025 full-year result was $916000.0, up 307.71% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at -$1.3 million, down from $930000.0 in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $1.2 million in Q2 2023, with the low at -$1.4 million in Q3 2023.
• Historically, Amortizatization of Intangibles has averaged $19000.0 across 5 years, with a median of $119000.0 in 2022.
• The largest YoY upside for Amortizatization of Intangibles was 1615.79% in 2023 against a maximum downside of 1310.92% in 2023.
• Kiniksa Pharmaceuticals International's Amortizatization of Intangibles stood at $203000.0 in 2022, then surged by 45.81% to $296000.0 in 2023, then tumbled by 376.69% to -$819000.0 in 2024, then jumped by 213.55% to $930000.0 in 2025, then slumped by 240.0% to -$1.3 million in 2026.
• The last three Amortizatization of Intangibles figures came in at -$1.3 million (Q1 2026), $930000.0 (Q4 2025), and -$603000.0 (Q3 2025), per Business Quant data.